Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2565 (LINC02565) is a non-coding RNA gene that does not encode a protein. It belongs to the long non-coding RNA (lncRNA) subclass, defined as RNA molecules longer than 200 nucleotides that do not overlap coding genes and typically lack protein-coding capacity[1][5][3]. LINC02565’s sequence is autonomously transcribed from intergenic regions of the genome. While many lncRNAs are known to remodel chromatin, regulate gene expression, and contribute to various biological processes and diseases, there is currently no direct evidence specifying the function, disease involvement, or therapeutic targeting of LINC02565. It is listed in major gene databases (GeneCards, BioGPS, Ensembl, NCBI) as a lncRNA, but no additional annotation for molecular activity, disease association, or druggability is available as of this writing[1][5][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2565 (LINC02565).